Ligand validation:6PW0

TRD: TRIDECANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6PW0_TRD_D_303	43%	75%	0.148	0.927	0.12	0.85	-	-	0	0	69%	1
6PW0_TRD_D_302	41%	73%	0.167	0.882	0.11	0.92	-	-	0	0	100%	1
6PW0_TRD_B_304	25%	77%	0.2	0.835	0.15	0.74	-	-	1	0	100%	1
6PW0_TRD_A_615	24%	79%	0.206	0.833	0.15	0.71	-	-	0	0	100%	1
6PW0_TRD_A_614	22%	77%	0.222	0.836	0.12	0.78	-	-	3	0	100%	1
6PW0_TRD_C_606	18%	76%	0.246	0.83	0.13	0.79	-	-	1	0	100%	1
6PW0_TRD_A_611	9%	77%	0.256	0.747	0.17	0.72	-	-	0	0	100%	1
6PW0_TRD_B_303	9%	88%	0.268	0.757	0.2	0.47	-	-	5	0	100%	1
6PW0_TRD_A_612	7%	76%	0.252	0.702	0.16	0.76	-	-	0	0	100%	1
6PW0_TRD_A_609	6%	77%	0.271	0.713	0.11	0.78	-	-	1	0	100%	1
6PW0_TRD_A_610	5%	75%	0.282	0.697	0.13	0.83	-	-	1	0	100%	1
6PW0_TRD_A_613	4%	88%	0.249	0.716	0.17	0.5	-	-	0	0	54%	1
6PW0_TRD_C_608	4%	77%	0.317	0.694	0.11	0.78	-	-	2	0	100%	1
6PW0_TRD_B_302	3%	81%	0.343	0.67	0.14	0.67	-	-	1	0	100%	1
6PW0_TRD_C_607	2%	78%	0.381	0.639	0.12	0.75	-	-	2	0	100%	1
3DTU_TRD_D_7	47%	81%	0.148	0.885	0.24	0.58	-	-	2	0	100%	1
6PW1_TRD_D_301	42%	76%	0.141	0.913	0.12	0.81	-	-	0	0	69%	1
2GSM_TRD_A_5007	41%	85%	0.15	0.862	0.22	0.51	-	-	2	0	100%	1
3OMA_TRD_D_3	32%	82%	0.206	0.882	0.2	0.59	-	-	1	0	100%	1
3OMI_TRD_D_303	30%	80%	0.192	0.853	0.21	0.63	-	-	1	0	100%	1
6GA3_TRD_A_303	59%	75%	0.109	0.891	0.12	0.84	-	-	0	0	100%	1
4ZR1_TRD_A_410	49%	75%	0.18	0.926	0.12	0.84	-	-	3	0	100%	1
6LPK_TRD_A_2422	41%	98%	0.14	0.853	0.14	0.14	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.